This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Practical aspects of using allopurinol

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Severe adverse reactions seem to be related to poor renal function:

  • check creatinine before initiating therapy
  • obtain consultant advice if creatinine is raised
  • monitor uric acid and creatinine 4 weekly as allopurinol is increased
  • check uric acid and creatinine yearly
  • start with 100mg daily, increase dose over 2-3 months
  • if minor side effects such as rash occur, stop therapy and consider reintroducing at a lower dose and increasing slowly
  • initiation of prophylactic therapy may provoke an acute gout attack and so an NSAID or colchicine should be given concomitantly for at least the first 3 months
  • prophylactic therapy should not be started during an acute attack because it can prolong symptoms
  • if an acute attack occurs during prophylactic treatment, this should be continued at the same dose while the acute attack is treated with an NSAID or colchicine

The summary of product characteristics should be consulted before prescribing this drug.

Reference:

  1. Drug and Therapeutics Bulletin (2004); 42(5):37-40.
  2. BMJ (1987); 294: 1504-1505

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.